Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review

Diabetic macular edema (DMO) is a leading cause of blindness in the working age population. Although anti-vascular endothelial growth factor (VEGF) therapy provided a major advance in treatment of DMO for many patients, there is a significant proportion of patients who maintain persistent DMO and ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusi-Rubiano, William, Blow, Rebecca R., Lane, Mark, Morjaria, Rupal, Denniston, Alastair K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258573/
https://www.ncbi.nlm.nih.gov/pubmed/30229441
http://dx.doi.org/10.1007/s40123-018-0145-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258573/
https://www.ncbi.nlm.nih.gov/pubmed/30229441
http://dx.doi.org/10.1007/s40123-018-0145-7

Ejemplares similares